289 related articles for article (PubMed ID: 35341972)
1. Primary Sjögren's syndrome is associated with increased risk of malignancies besides lymphoma: A systematic review and meta-analysis.
Zhong H; Liu S; Wang Y; Xu D; Li M; Zhao Y; Zeng X
Autoimmun Rev; 2022 May; 21(5):103084. PubMed ID: 35341972
[TBL] [Abstract][Full Text] [Related]
2. Primary Sjogren's syndrome and malignancy risk: a systematic review and meta-analysis.
Liang Y; Yang Z; Qin B; Zhong R
Ann Rheum Dis; 2014 Jun; 73(6):1151-6. PubMed ID: 23687261
[TBL] [Abstract][Full Text] [Related]
3. Risk of malignancy in Korean patients with primary Sjögren's syndrome.
Kang J; Kim H; Kim J; Choi S; Jung SY; Jang EJ; Cho SK; Sung YK
Int J Rheum Dis; 2020 Aug; 23(9):1240-1247. PubMed ID: 32841507
[TBL] [Abstract][Full Text] [Related]
4. The risk of cancer in patients with primary Sjögren syndrome: a single-center study from Turkey.
Aslan B; Öğüt TS; Erbasan F; Dilbil M; Çelik E; Terzioğlu ME; Yazısız V
Turk J Med Sci; 2022 Jun; 52(3):587-595. PubMed ID: 36326315
[TBL] [Abstract][Full Text] [Related]
5. Risk, Incidence, and Mortality of Breast Cancer in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis.
Deng J; Liu M; Xiao R; Wang J; Liao X; Ye Z; Sun Z
Front Immunol; 2022; 13():904682. PubMed ID: 35844507
[TBL] [Abstract][Full Text] [Related]
6. Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjogren's syndrome in Taiwan.
Weng MY; Huang YT; Liu MF; Lu TH
Ann Rheum Dis; 2012 Apr; 71(4):524-7. PubMed ID: 22072014
[TBL] [Abstract][Full Text] [Related]
7. The risk of lymphoma development in autoimmune diseases: a meta-analysis.
Zintzaras E; Voulgarelis M; Moutsopoulos HM
Arch Intern Med; 2005 Nov; 165(20):2337-44. PubMed ID: 16287762
[TBL] [Abstract][Full Text] [Related]
8. Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland).
Kauppi M; Pukkala E; Isomäki H
Cancer Causes Control; 1997 Mar; 8(2):201-4. PubMed ID: 9134244
[TBL] [Abstract][Full Text] [Related]
9. Systemic lupus erythematous and malignancy risk: a meta-analysis.
Cao L; Tong H; Xu G; Liu P; Meng H; Wang J; Zhao X; Tang Y; Jin J
PLoS One; 2015; 10(4):e0122964. PubMed ID: 25885411
[TBL] [Abstract][Full Text] [Related]
10. Incidence of cancer in a cohort of patients with primary Sjögren syndrome in Argentina.
Brom M; Moyano S; Gandino IJ; Scolnik M; Soriano ER
Rheumatol Int; 2019 Oct; 39(10):1697-1702. PubMed ID: 31471716
[TBL] [Abstract][Full Text] [Related]
11. The risk of developing non-Hodgkin lymphoma and the mortality rate in primary Sjögren's syndrome: a single-centre, retrospective cohort study.
Mayer M; Martinic M; Reihl-Crnogaj M; Anic B
Rheumatol Int; 2023 Nov; 43(11):2031-2036. PubMed ID: 37491526
[TBL] [Abstract][Full Text] [Related]
12. The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China.
Zhou Z; Liu H; Yang Y; Zhou J; Zhao L; Chen H; Fei Y; Zhang W; Li M; Zhao Y; Zeng X; Zhang F; Yang H; Zhang X
Cancer Commun (Lond); 2022 May; 42(5):435-446. PubMed ID: 35357093
[TBL] [Abstract][Full Text] [Related]
13. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors.
Theander E; Henriksson G; Ljungberg O; Mandl T; Manthorpe R; Jacobsson LT
Ann Rheum Dis; 2006 Jun; 65(6):796-803. PubMed ID: 16284097
[TBL] [Abstract][Full Text] [Related]
14. Risk of non-Hodgkin's lymphoma and thyroid cancer in primary Sjögren's syndrome measured using the Korean Health Insurance Claims Database.
Ahn JK; Hwang J; Seo GH
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):40-46. PubMed ID: 31969226
[TBL] [Abstract][Full Text] [Related]
15. A retrospective study of long-term outcomes in 152 patients with primary Sjogren's syndrome: 25-year experience.
Abrol E; González-Pulido C; Praena-Fernández JM; Isenberg DA
Clin Med (Lond); 2014 Apr; 14(2):157-64. PubMed ID: 24715127
[TBL] [Abstract][Full Text] [Related]
16. Risk, predictors, and clinical characteristics of lymphoma development in primary Sjögren's syndrome.
Solans-Laqué R; López-Hernandez A; Bosch-Gil JA; Palacios A; Campillo M; Vilardell-Tarres M
Semin Arthritis Rheum; 2011 Dec; 41(3):415-23. PubMed ID: 21665245
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary nodules in patients with primary Sjögren's syndrome: Causes, clinico-radiologic features, and outcomes.
Casal Moura M; Navin PJ; Johnson GB; Hartman TE; Baqir M; Yi ES; Ryu JH
Respir Med; 2020; 174():106200. PubMed ID: 33147563
[TBL] [Abstract][Full Text] [Related]
18. Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization database.
Goulabchand R; Malafaye N; Jacot W; Witkowski Durand Viel P; Morel J; Lukas C; Rozier P; Lamure S; Noel D; Molinari N; Mura T; Guilpain P
Autoimmun Rev; 2021 Dec; 20(12):102987. PubMed ID: 34718160
[TBL] [Abstract][Full Text] [Related]
19. Incidence of cancer in a cohort of patients with primary Sjogren's syndrome.
Lazarus MN; Robinson D; Mak V; Møller H; Isenberg DA
Rheumatology (Oxford); 2006 Aug; 45(8):1012-5. PubMed ID: 16490754
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and risk factors of interstitial lung disease in patients with primary Sjögren's syndrome: A systematic review and meta-analysis.
He C; Chen Z; Liu S; Chen H; Zhang F
Int J Rheum Dis; 2020 Aug; 23(8):1009-1018. PubMed ID: 32588976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
